Lunai Bioworks
LNAI
33 hedge funds and large institutions have $10.8M invested in Lunai Bioworks in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,700% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
68% more capital invested
Capital invested by funds: $6.43M → $10.8M (+$4.35M)
14% more funds holding
Funds holding: 29 → 33 (+4)
0.02% more ownership
Funds ownership: 0.04% → 0.06% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.06M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$893K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$891K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$601K |
| 5 |
State Street
Boston,
Massachusetts
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$151K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$59K |
| 3 |
Squarepoint
New York
|
-$56K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$10K |
LNAI Hedge Fund Activity: Q4 2019 in Review
33 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2019, worth a combined $10.8M — up 68% from $6.43M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LNAI positions and 4 closed out — a net gain of 4 holders — while 18 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, adding an estimated $2.06M. The largest seller was Millennium Management, exiting entirely with an estimated $151K sold.
- 33 institutional investors held Lunai Bioworks (LNAI) as of Q4 2019, up from 29 in Q3 2019.
- Funds reported $10.8M of Lunai Bioworks stock for Q4 2019, up 68% quarter-over-quarter.
- 8 funds opened new Lunai Bioworks positions in Q4 2019 and 4 closed out, a net change of +4 holders.
- The largest Lunai Bioworks buyer in Q4 2019 was BlackRock, an estimated $2.06M added.
- The largest Lunai Bioworks seller in Q4 2019 was Millennium Management, an estimated $151K sold.
Based on aggregated 13F filings for Q4 2019.